Indivior Pharmaceuticals Operating Income Growth & History (INDV)

Indivior Pharmaceuticals's operating income was $262.0M for fiscal 2025.

View full Indivior Pharmaceuticals company overview

Indivior Pharmaceuticals annual operating income history

Indivior Pharmaceuticals annual operating income

Fiscal yearPeriod endedOperating incomeChangeGrowth
20252025-12-31$262.0M$224.0M+589.47%
20242024-12-31$38.0M$190.0M
20232023-12-31−$152.0M−$71.0M
20222022-12-31−$81.0M−$294.0M
20212021-12-31$213.0M

Indivior Pharmaceuticals operating income trends

Between the periods ended 2021-12-31 and 2025-12-31, Indivior Pharmaceuticals's operating income increased from $213.0M to $262.0M, a change of $49.0M. The latest reported quarter, Q2 2026, shows $160.0M.

About the metric

What operating income means

Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.

Calculation and source

SEC-reported operating income

TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Indivior Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about INDV yet. Start the conversation.

Write the first post